Why Isn't IBM's Stock Bouncing Back After Strong Earnings Results?

IBM (IBM) posted Q3 2026 results with 5% revenue growth and a raised free cash flow outlook, yet the stock failed to stage a meaningful rebound. The market is looking past the headline beat.

The reason sits in the software line. Software revenue grew 9%, but roughly half of that came from the Confluent acquisition, which puts organic software growth near 4%. Strip out the deal, and the growth story looks far less dynamic than the top-line figure suggests.

Guidance reinforces the caution. Management's outlook points to slower growth ahead. Mainframe hardware sales fell 20%, and transaction processing is expected to be flat for the year. Those are two core franchise indicators moving sideways or sharply lower.

The analyst behind the source piece remains bullish on the long term, citing IBM's established enterprise customer base, positioning in enterprise AI and quantum computing, and a reliable dividend. That is a long-duration thesis, not a near-term catalyst. Interpretation: the muted price reaction suggests investors are weighting acquisition-aided growth and decelerating guidance more heavily than the free cash flow raise.